Print This Page

Workshop #284):  Neurofeedback and Asthma: Is asthma the undetected variable dragging out your cases? 

The domination of asthma in my Midwestern region plays a clear role in multiple Bi-polar, ADD/ADHD, Mood Disorder, Migraine and TMJ cases. On average 66% of cases annually display amplitude variances correlated with allergies observable in their EEG's. Of those cases, 45% have poorly managed/undiagnosed asthma perpetuating presenting mental health issues.

Understanding how to detect and assist with respiratory management, combined with Neurofeedback accelerates resolving outcomes. EEG baselines can track asthma and offer clarity on mental health struggles. Interlacing Neurofeedback to stabilize conditions and educate families; recognizing these respiratory cues verses emotional deficits has proven critical for many.

Plenary #291):  Neurofeedback and Asthma: Is Asthma the undetected variable dragging out your cases? 

The domination of asthma in my Midwestern region plays a clear role in multiple Bi-polar, ADD/ADHD, Mood Disorder, Migraine and TMJ cases. On average 66% of cases annually display amplitude variances correlated with allergies observable in their EEG's. Of those cases, 45% have poorly managed/undiagnosed asthma perpetuating presenting mental health issues. This presentation will look at an overview on cases utilizing Neurofeedback for detection and assistance with respiratory management to accelerate resolving outcomes.

Details:

Workshop #284):  Neurofeedback and Asthma: Is asthma the undetected variable dragging out your cases?

The domination of asthma in my Midwestern region plays a clear role in multiple Bi-polar, ADD/ADHD, Mood Disorder, Migraine and TMJ cases. On average 66% of cases annually display amplitude variances correlated with allergies observable in their EEG's. Of those cases, 45% have poorly managed/undiagnosed asthma perpetuating presenting mental health issues.

Molly Raaymakers with the wonderful assistance of Dr. Edward O’Malley present this workshop together. The workshop will look at understanding how to detect and assist with respiratory management through the use of Neurofeedback to accelerate your outcomes. Dr. Edward O’Malley will focus on how respiratory difficulties left unmanaged deteriorate sleep and undermine the effectiveness of neurofeedback training. Molly will discuss asthma detection with the assistance of EEG and how continuing neurofeedback allows follow-up EEG monitoring, provides clarity on mental health struggles, and offers resolution to clients who otherwise present as chronic and with limited responsiveness. Cases presented involve both Neurofeedback in the office or with additional use of a home training system, offering opportunity for significant relief and personal monitoring for the asthmatic client. Interlacing Neurofeedback to stabilize conditions and educate families; recognizing these respiratory cues verses emotional deficits has proven critical for many clients.

The percentage of allergy and asthma conditions is on the rise. Beta (23-38) plays a key cuing role in the suspicion of asthma as a factor in client’s emotional and/or cognitive presentation. EEG data in addition to standard allergy symptom awareness and peak flow monitoring substantiates referring clients for Pulmonary Function Testing and diagnostics. In some cases the EEG may be the only primary cue for directing appropriate pulmonary evaluation. Once confirmed, the EEG continues to provide a reliable tool in ensuring proper management of the condition. Many times cases have not had obvious physical symptoms from which to cue effective respiratory management, yet the EEG data has effectively provided the information on the clients pulmonary circumstances. Even with cases that do have common symptoms such as persistent dry coughs, I see emotional and cognitive ‘slips’ within the EEG as well as on observation of client’s presentation occurring 3-6 weeks prior to the onset of the psychical cough. With children in particular, these events concur with the start and end of the school year. Early August and mid-March are key environmental periods where the pollen count in Michigan accelerates. Allergy and asthmatic reactivity also accelerates, and not surprising so do referrals for neuropsychological evaluations, ADD/ADHD diagnosing, and prescribing of attention and mood managing medications.

Typically, these clients present with a history of mental health diagnostics and report little benefit to traditional management of their mental health symptoms. Clients responsiveness to Neurofeedback is either slow/ less efficient, or after achieving great progress regresses quickly during particular seasonal changes. This workshop will review, detail and discuss multiple facets involving allergy/asthma and how to accelerate progress with these cases through Neurofeedback.

Plenary #291):  Neurofeedback and Asthma: Is Asthma the undetected variable dragging out your cases?

The domination of asthma in my Midwestern region plays a clear role in multiple Bi-polar, ADD/ADHD, Mood Disorder, Migraine and TMJ cases. On average 66% of cases annually display amplitude variances correlated with allergies observable in their EEG's. Of those cases, 45% have poorly managed/undiagnosed asthma perpetuating presenting mental health issues.

Understanding how to detect and assist with respiratory management, combined with Neurofeedback accelerates resolving outcomes. Left unmanaged, respiratory difficulties deteriorate sleep and undermine the effectiveness of neurofeedback training. Asthma can be detected with the assistance of EEG. Continuing neurofeedback allows follow-up EEG monitoring, provides clarity on mental health struggles, and offers resolution to clients who otherwise present as chronic and with limited responsiveness. Whether in the office or with additional use of a home training system, neurofeedback offers opportunity for significant relief and personal monitoring for the asthmatic client. Interlacing Neurofeedback to stabilize conditions and educate families; recognizing these respiratory cues verses emotional deficits has proven critical for many.

The percentage of allergy and asthma conditions is on the rise. Beta (23-38) plays a key cuing role in the suspicion of asthma as a factor in client’s emotional and/or cognitive presentation. Even with cases that do have common symptoms such as persistent dry coughs, I see emotional and cognitive ‘slips’ within the EEG as well as on observation of client’s presentation occurring 3-6 weeks prior to the onset of the psychical cough. With children in particular, these events concur with the start and end of the school year. Early August and mid-March are key environmental periods where the pollen count in Michigan accelerates. Allergy and asthmatic reactivity also accelerates, and not surprising so do referrals for neuropsychological evaluations, ADD/ADHD diagnosing, and prescribing of attention and mood managing medications.

Typically, these clients present with a history of mental health diagnostics and report little benefit to traditional management of their mental health symptoms. Clients responsiveness to Neurofeedback is either slow/ less efficient, or after achieving great progress regresses quickly during particular seasonal changes. This presentation will look at an overview on Asthma and cases where EEG provided detection for respiratory diagnosing with management and clarification to behavioral, cognitive and emotional re-occurring symptoms.

Co-presenter with Valdeane Brown of CARE® in the Real World

Click to View All Speakers